THE ROLE OF NEUTRAL ENDOPEPTIDASE IN DOGS WITH EVOLVING CONGESTIVE-HEART-FAILURE

被引:38
作者
MARGULIES, KB
BARCLAY, PL
BURNETT, JC
机构
[1] PFIZER LTD,CENT RES,SANDWICH,KENT,ENGLAND
[2] MAYO CLIN & MAYO FDN,DEPT INTERNAL MED,ROCHESTER,MN
关键词
HEART FAILURE; NATRIURETIC PEPTIDES; SODIUM; ATRIAL NATRIURETIC FACTOR;
D O I
10.1161/01.CIR.91.7.2036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Recent studies suggest that neurohumoral mechanisms including decreased renal responses to increases in atrial natriuretic factor (ANF) play a central role in the progression from asymptomatic cardiac dysfunction to advanced congestive heart failure (CHF) with sodium retention, vasoconstriction, and reduced exercise tolerance. Recognizing that neutral endopeptidase 24.11 degrades ANF and may be enhanced in CHF, we hypothesized that chronic neutral endopeptidase inhibition (NEP-I) would potentiate renal responses to exogenous ANF and alter the temporal evolution of sodium retention in evolving CHF by potentiation of increased endogenous ANF. Methods and Results We studied 13 conscious dogs with evolving CHF produced by rapid ventricular pacing at 250 beats per minute. Six of these dogs received NEP-I with candoxatril, 10 mg/kg PO BID, throughout evolving CHF. Responses to exogenous ANF, 10 mu g/kg IV bolus, were assessed at baseline and after 6 days of CHF. Daily metabolic studies during evolving CHF with chronic NEP-I showed increased sodium excretion and renal cGMP generation consistent with enhanced renal activity of endogenous ANF compared with untreated controls. In addition, renal natriuretic and cGMP responses to exogenous ANF were intact in CHF with chronic NEP-I in contrast to markedly attenuated renal responses to exogenous ANF in untreated CHF, Despite enhanced ANF responsiveness and improved sodium balance in evolving CHF, a moderate degree of sodium retention was observed during chronic NEP-I in evolving CHF. Conclusions Enzymatic degradation by neutral endopeptidase limits local renal responses to increases in endogenous and exogenous ANF in CHF independent of changes in systemic hemodynamics or augmented plasma concentrations of ANF. The moderate sodium retention observed during evolving CHF despite chronic NEP-I probably reflects the antinatriuretic effects of hemodynamic and humoral factors independent of ANF activity.
引用
收藏
页码:2036 / 2042
页数:7
相关论文
共 36 条
[31]  
TAMBURINI PP, 1989, J PHARMACOL EXP THER, V251, P956
[32]   THIORPHAN, AN INHIBITOR OF ENDOPEPTIDASE 24.11, POTENTIATES THE NATRIURETIC ACTIVITY OF ATRIAL NATRIURETIC PEPTIDE [J].
TRAPANI, AJ ;
SMITS, GJ ;
MCGRAW, DE ;
SPEAR, KL ;
KOEPKE, JP ;
OLINS, GM ;
BLAINE, EH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 (03) :419-424
[33]  
VIJAYARAGHAVAN J, 1990, J BIOL CHEM, V265, P14150
[34]   CAPTOPRIL ENHANCES RENAL RESPONSIVENESS TO ANF IN DOGS WITH COMPENSATED HIGH-OUTPUT HEART-FAILURE [J].
VILLARREAL, D ;
FREEMAN, RH ;
JOHNSON, RA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (03) :R509-R516
[35]   RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN CONGESTIVE FAILURE IN CONSCIOUS DOGS [J].
WATKINS, L ;
BURTON, JA ;
HABER, E ;
CANT, JR ;
SMITH, FW ;
BARGER, AC .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (06) :1606-1617
[36]   MAXIMIZING THE NATRIURETIC EFFECT OF ENDOGENOUS ATRIOPEPTIN IN A RAT MODEL OF HEART-FAILURE [J].
WILKINS, MR ;
SETTLE, SL ;
STOCKMANN, PT ;
NEEDLEMAN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6465-6469